| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/01/27 | 06 : 07 | Alliance News |  Sanofi and Regeneron celebrate Dupixent's FDA approval | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2023/12/12 | 04 : 25 | Alliance News | Leading pharmaceutical firms highlight positive trial data on lymphoma | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2022/09/16 | 13 : 46 | Alliance News | Regeneron, Sanofi drug effective for young children with severe eczema | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2022/09/09 | 14 : 40 | Alliance News | Regeneron shares surge on positive Eylea trial data | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2022/06/02 | 23 : 18 | Alliance News | Sanofi grants Regeneron global license for cancer treatment Libtayo | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2022/05/31 | 14 : 54 | Alliance News | US FDA accepts Regeneron and Sanofi's Dupixent for priority review | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2022/03/28 | 14 : 18 | Alliance News | IN BRIEF: Sanofi, Regeneron hail positive results in prurigo nodularis | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2022/02/28 | 15 : 21 | Alliance News | Sanofi and Regeneron note positive new data for Dupixent | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2022/02/18 | 19 : 26 | Alliance News | Regeneron and Sanofi stop trial of skin condition treatment Dupixent | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2022/01/19 | 16 : 32 | Alliance News | Sanofi and Regeneron's Dupixent meets endpoints for skin treatment | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/11/13 | 00 : 54 | Alliance News | TOP NEWS: Roche and Regeneron Covid antibody cocktail approved in EU | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/10/25 | 14 : 50 | Alliance News | Sanofi and Regeneron's Dupixent trial meets primary endpoints | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/10/14 | 21 : 18 | Alliance News | US FDA accepts Regeneron's REGEN-COV application for priority review | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/09/30 | 14 : 36 | Alliance News | Regeneron, Roche drug cocktail reduces Covid-19 viral load - UK study | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/08/30 | 15 : 23 | Alliance News | Sanofi, Regeneron's Dupixent works for children with atopic dermatitis | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/07/27 | 20 : 56 | Alliance News | AstraZeneca partners with Regeneron to research obesity treatment | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/07/20 | 14 : 58 | Alliance News | Roche and Regeneron's Covid antibody cocktail gets Japan approval | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/06/28 | 14 : 16 | Alliance News | Sanofi, Regeneron report well-established safety profile of Dupixent | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/06/25 | 14 : 48 | Alliance News | Sanofi and Regeneron's cancer treatment Libtayo gets approval in EU | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/03/23 | 16 : 26 | Alliance News | TOP NEWS: Novartis, Regeneron Covid antibody cocktail excels in trials | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/03/15 | 18 : 20 | Alliance News | Regeneron, Sanofi report positive phase three trial results of Libtayo | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/02/27 | 02 : 25 | Alliance News | EU Medicines Regulator Approves Regeneron Coronavirus Therapy | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/02/25 | 23 : 05 | Alliance News | Roche, Regeneron Note Positive Findings For REGEN-COV In Covid-19 | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/02/23 | 05 : 13 | Alliance News | IN BRIEF: Sanofi, Regeneron Get US FDA Approval For Lung Cancer Drug | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2021/01/13 | 15 : 24 | Alliance News | Roche Says US To Buy Extra Doses Of Regeneron's Covid Antibody Coctail | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2020/12/02 | 07 : 27 | Alliance News | Regeneron Pharmaceuticals Developing Nasal Spray To Prevent Covid-19 | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2020/11/30 | 18 : 59 | Alliance News | Sanofi And Regeneron Announce New Dupixent Approval In Children | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2020/10/26 | 21 : 52 | Alliance News | Sanofi, Regeneron Say Dupixent Lowers Esophagitis Symptoms | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2020/10/16 | 22 : 19 | Alliance News | Sanofi And Regeneron Get European Boost For Dupixent | LSE:0R2M | Regeneron Pharmaceuticals Inc |
| 2020/10/13 | 14 : 35 | Alliance News | Sanofi And Regeneron Say Dupixent Significantly Reduces Asthma Attacks | LSE:0R2M | Regeneron Pharmaceuticals Inc |